News
Collaboration combines Nuclera's eProtein Discovery System, which accelerates protein expression, purification and ...
Ailsa Craig and Marek Poszepczynski, portfolio managers at the International Biotechnology Trust, tell MoneyWeek where they’d ...
Take a closer look at London's biotech hub – renowned for its thriving life sciences ecosystem and world-class infrastructure ...
Summit Therapeutics said its closely tracked antibody, the first lung cancer drug to beat Merck’s Keytruda in a head-to-head ...
Taysha Gene Therapies' positive results from the REVEAL study showcase TSHA-102's promise in treating Rett Syndrome. Click ...
While a Trump administration decision to recompete several Tech Hub awards prompted frustration among supporters of the ...
ZURICH, SWITZERLAND, May 29, 2025 -- VERAXA Biotech AG (“VERAXA”), an emerging leader in designing novel cancer therapies and proposed de-SPAC acquisition target of Voyager Acquisition Corp.
In this era of escalating trade tensions and geopolitical uncertainty, the U.S. cannot afford to cede another critical ...
Tijuana has long been recognized as an important hub of manufacturing and production in the San Diego-Tijuana binational ...
With 14 drugs posting double-digit sales growth in the most recent quarter, a promising obesity drug in late-stage trials, ...
But on Wednesday, May 28 Moderna revealed the HHS has terminated the award for late-stage development and right to purchase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results